Apoptosis and Fas expression in human fetal membranes

Journal of Clinical Endocrinology and Metabolism

Volumn 83, Issue 2, 1998, Pages 660-666

  Runić, Radmila ^a   Lockwood, Charles J ^a   Lachapelle, Linda ^a   Dipasquale, Bruno ^a   Demopoulos, Rita I ^a   Kumar, Asok ^a   Guller, Seth ^a,b  

^a NEW YORK UNIVERSITY   (United States)

^b NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMNION; APOPTOSIS; ARTICLE; CELL DEATH; CELL SURFACE; CHROMATIN; DECIDUA; ENZYME ACTIVITY; FETUS; FETUS MEMBRANE; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; REPRODUCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STATISTICAL ANALYSIS;

AMNION; ANTIGENS, CD95; APOPTOSIS; BLOTTING, NORTHERN; CHORION; DECIDUA; EPITHELIUM; EXTRAEMBRYONIC MEMBRANES; FEMALE; GESTATIONAL AGE; HUMANS; IMMUNOHISTOCHEMISTRY; LABOR, OBSTETRIC; MICROSCOPY, ELECTRON; OBSTETRIC LABOR, PREMATURE; PREGNANCY; RNA, MESSENGER; TROPHOBLASTS;

EID: 0031787357     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.83.2.660     Document Type: Article

References (40)

1. Cunningham FG, MacDonald PC, Gant NF, Leveno KJ, Glistrap III LC. 1993 Parturition: biomolecular and physiological processes. In: Williams obstetrics, 19th Ed. Stamford: Appleton and Lange; 345-356.
2. Lockwood CJ. 1994 Recent advances in elucidating the pathogenesis of preterm delivery, the detection of patients at risk, and preventive therapies. Curr Opin Obstet Gynecol. 6:7-18.
3. Artal R, Sokol RJ, Newman M, Burstein AH, Stojkov J. 1976 The mechanical properties of prematurely ruptured and non-prematurely ruptured fetal membranes. Am J Obstet Gynecol. 125:655-659.
4. Malak TM, Bell SC. 1993 Structural characteristics of term human fetal membranes: a novel zone of extreme morphological alteration within the rupture site. Br J Obstet Gynaecol. 101:375-386.
5. Gerschenson LE, Rotello RJ. 1992 Apoptosis: a different type of cell death. FASEB J. 6:2450-2455.
6. Vaux DL. 1993 Toward an understanding of the molecular mechanisms of physiological cell death. Proc Natl Acad Sci USA. 90:786-789.
7. Nagata S, Goldstein P. 1995 The Fas death factor. Science. 267:1449-1456.
8. Tilly JL, Kowalski KI, Johnson AL, Hsueh AJW. 1991 Involvement of apoptosis in ovarian follicular atresia and postovulatory regression. Endocrinology. 129:2799-2801.
9. Kawakami A, Eguchi K, Matsuoka N, et al. 1996 Thyroid-stimulating hormone inhibits Fas antigen-mediated apoptosis of human thyrocytes in vitro. Endocrinology. 137:3163-3169.
10. Griffith TS, Brunner T, Fletcher SM, Green DR, Ferguson TA. 1995 Fas ligand-induced apoptosis as a mechanism of immune privilege. Science. 270:1189-1192.
11. Bellgrau D, Gold D, Selawry H, Moore J, Franzusoff, Duke RC. 1995 A role for CD95 ligand in preventing graft rejection. Nature. 377:630-632.
12. Runić R, Lockwood CJ, Ma Y, DiPasquale B, Guller S. 1996 Expression of Fas ligand by human cytotrophoblasts: implications in placentation and fetal survival. J Clin Endocrinol Metab. 81:3119-3122.
13. Lockwood CJ, Senyei AE, Dische MR, et al. 1991 Fetal fibronectin in cervical and vaginal secretions as a predictor of preterm delivery. N Engl J Med. 325:669-674.
14. Kumar RA, Phillips DM. 1991 Spermiation and sperm maturation in the marmoset. Anat Rec. 229:315-320.
15. Tachibana O, Nakazawa H, Lampe J, Watanabe K, Kleihues P, Ohgaki H. 1995 Expression of Fas/APO-1 during the progression of astrocytomas. Cancer Res. 55:5528-5530.
16. Apostolakos MJ, Schuermann WH, Frampton MW, Utell MJ, Willey JC. 1993 Measurement of gene expression by multiplex competitive polymerase chain reaction. Anal Biochem. 213:277-284.
17. Guller S, Lacroix N, Krikun G, et al. 1993 Steroid regulation of oncofetal fibronectin expression in human cytotrophoblasts. J Steroid Biochem Mol Biol. 46:1-10.
18. Sambrook J, Fritsch EF, Maniatis T. 1989 Molecular cloning: a laboratory manual, 2nd Ed. Cold Spring Harbor Cold Spring Harbor Laboratory; 7.37-7.45.
19. Guller S, Markiewicz L, Wozniak R, et al. 1944 Developmental regulation of glucocorticoid-mediated effects on extracellular matrix protein expression in human placenta. Endocrinology. 134:2064-2071.
20. Lazebnik YA, Cole S, Cooke CA, Nelson WG, Earnshaw WC. 1943 Nuclear events of apoptosis in vitro in cell-free mitotic extracts: a model system for analysis of the active phase of apoptosis. J Cell Biol. 123:7-22.
21. Kokawa K, Shikone T, Nakano R. 1996 Apoptosis in the human uterine endometrium during the menstrual cycle. J Clin Endocrinol Metab. 81:4144-4147.
22. Feng Z, Marti A, Jehn B, Altermatt HJ, Chicaiza G, Jaggi R. 1995 Glucocorricoid and progesterone inhibit involution and programmed cell death in the mouse mammary gland. J Cell Biol. 131:1095-1103.
23. Furuya Y, Isaacs JT. 1993 Differential gene regulation during programmed cell death (apoptosis) vs. proliferation of prostatic glandular cells induced by androgen manipulation. Endocrinology. 133:2660-2666.
24. Tenniswood MP, Guenette S, Lakins J, Mooibroek M, Wong P, Welsh J-E. 1992 Active cell death in hormone dependent tissues. Cancer Metas Rev. 11:197-220.
25. Wyllie AH, Arenas MJ, Morris RG, Walker SW, Evan G. 1992 The apoptosis endonuclease and its regulation. Semin Immunol. 4:389-397.
26. Tornusciolo DR, Schmidt RE, Roth KA. 1995 Simultaneous detection of TDT-mediated dUTP-biotin nick end labeling (TUNEL)-positive cells and immunohistochemical markers in single tissue sections. Biotechniques. 19:800-805.
27. Lang R, Lustig, M, Francois F, Sellinger M, Plesken H. 1994 Apoptosis during macrophage-dependent ocular tissue remodeling. Development. 120:3395-3403.
28. Yasuda M, Umemura S, Osamura RY, Kenjo T, Tsutsumi Y. 1995 Apoptotic cells in the human endometrium and placental villi: pitfalls in applying the TUNEL method. Arch Histol Cytol. 58:185-190.
29. Wong P, Smith SB, Bora N, Gentleman S. 1994 The use of C0t-1 probe DNA for the detection of low levels of DNA fragmentation. Biochem Cell Biol. 72:649-653.
30. Schulze-Osthoff K, Walczak H, Droge W, Krammer PH. 1994 Cell nucleus and DNA fragmentation are not required for apoptosis. J Cell Biol. 127:15-20.
31. Pandey S, Walker PR, Sikorska M. 1994 Separate pools of endonuclease activity are responsible for internucleosomal and high molecular mass DNA fragmentation during apoptosis. Biochem Cell Biol. 72:625-629.
32. Yui J, Garcia-Lloret M, Wegmann TG, Guilbert LJ. 1994 Cytotoxicity of tumour necrosis factor-alpha and gamma-interferon against primary human placental trophoblasts. Placenta. 15:819-835.
33. Lei H, Furth EE, Kalluri R, et al. 1996 A program of cell death and extracellular matrix degradation is activated in the amnion before the onset of labor. J Clin Invest. 98:1971-1978.
34. Kajstura J, Cheng W, Reiss K, et al. 1996 Apoptotic and necrotic myocyte cell deaths are independent contributing variables of infarct size in rats. Lab Invest. 74:86-107.
35. Guller S, Kong L, Wozniak R, Lockwood CJ. 1995 Reduction of extracellular matrix protein expression in human amnion epithelial cells by glucocorticoids: a potential role in preterm rupture of the fetal membranes. J Clin Endocrinol Metab. 80:2244-2250.
36. Boldin MP, Goncharov TM, Goltsev YV, Wallach D. 1996 Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1- and TNF receptor-induced cell death. Cell. 85:803-815.
37. Muzio M, Chinnaiyan AM, Kischkel FC, et al. 1996 FLICE, a novel FADD-homologous ICE/CED-3-like protease is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex. Cell. 85:817-827.
38. Saas P, Walker PR, Hahne M, et al. 1997 Fas ligand expression by astrocytoma in vivo: maintaining immune privilege in the brain? J Clin Invest. 99:1173-1178.
39. O'Connell J, O'Sullivan GC, Collins JK, Shanahan FS. 1996 The Fas counterattack: Fas-mediated killing by colon cancer cells expressing Fas ligand. J Exp Med. 184:539-548.
40. Tanaka M, Suda T, Haze K, et al. 1996 Fas ligand in human serum. Nat Med. 2:317-322.